(Q45408181)

14 December 2017

Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS. (English)

1 reference

14 December 2017

Gumei Liu

1

1 reference

14 December 2017

Yong Hong Chen

2

1 reference

14 December 2017

Xiaohua He

3

1 reference

14 December 2017

Inês Martins

4

1 reference

14 December 2017

Jason A Heth

5

1 reference

14 December 2017

John A Chiorini

6

1 reference

14 December 2017

Beverly L Davidson

7

1 reference

14 December 2017

1 February 2007

1 reference

14 December 2017

1 reference

14 December 2017

15

1 reference

14 December 2017

2

1 reference

14 December 2017

242-247

1 reference

Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis

14 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Neuropathology of murine mucopolysaccharidosis type VII.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Behavioural abnormalities in a murine model of a human lysosomal storage disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-defici

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Identification of PDGFR as a receptor for AAV-5 transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Gene therapy of the brain in the dog model of Hurler's syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

NMDA receptors, place cells and hippocampal spatial memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Glutamate receptor function in learning and memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Spatial memory dissociations in mice lacking GluR1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Reduction of NR1 and phosphorylated Ca2+/calmodulin-dependent protein kinase II levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

AMPA Receptor Trafficking at Excitatory Synapses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Homeostatic plasticity and NMDA receptor trafficking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Synaptic plasticity and AMPA receptor trafficking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300016

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300016

1 reference

14 December 2017

1 reference